Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab.
S James TalksDevangna BhatiaGeeta MenonAbosede ColeHaralabos EleftheriadisLouise DowneyNgai Victor ChongSobha Sivaprasadnull nullPublished in: Eye (London, England) (2019)
The addition of targeted PRP to areas of non-perfusion in a patient with DMO does not reduce the number of injections required in the first year. It seems most likely that local VEGF at the macula is the main cause of DMO.
Keyphrases
- platelet rich plasma
- diabetic retinopathy
- age related macular degeneration
- optical coherence tomography
- case report
- vascular endothelial growth factor
- type diabetes
- endothelial cells
- cancer therapy
- study protocol
- open label
- wound healing
- contrast enhanced
- newly diagnosed
- ultrasound guided
- magnetic resonance
- drug delivery